Inflammatory Biomarker Reduction With Fostemsavir Over 96 Weeks in Heavily Treatment-Experienced Adults With Multidrug-Resistant HIV-1 in the BRIGHTE Study

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2024-08-26
DOI
https://doi.org/10.1093/ofid/ofae469
Citations
4
Primary Topic
HIV-related health complications and treatments
Type
article
Field-Weighted Citation Impact
2.76

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Inflammatory Biomarker Reduction With Fostemsavir Over 96 Weeks in Heavily Treatment-Experienced Adults With Multidrug-Resistant HIV-1 in the BRIGHTE Study

José Castillo‐Mancilla, Marcia Wang, Shiven Chabria, Fangfang Du et al.
4 citations
Open Forum Infectious Diseases
HIV-related health complications and treatments
2.76
article

Inflammatory Biomarker Reduction With Fostemsavir Over 96 Weeks in Heavily Treatment-Experienced Adults With Multidrug-Resistant HIV-1 in the BRIGHTE Study

José Castillo‐Mancilla, Marcia Wang, Shiven Chabria, Fangfang Du, Andrew Clark, Manyu Prakash, Amy Pierce, Allan R. Tenorio
article en
4 citations

Abstract

No abstract available for this paper.
Open Forum Infectious DiseasesVol. 11(9)
ViiV Healthcare (Spain) (ES), ViiV Healthcare (United Kingdom) (GB), GlaxoSmithKline (United States) (US)
ViiV Healthcare
Good health and well-being
Openalex Percentile: Top 10%
HIV-related health complications and treatments
2.76
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.